Short and long-term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registry
-
Published:2018-10
Issue:8
Volume:48
Page:839-851
-
ISSN:0269-2813
-
Container-title:Alimentary Pharmacology & Therapeutics
-
language:en
-
Short-container-title:Aliment Pharmacol Ther
Author:
Chaparro María1ORCID, Garre Ana1, Ricart Elena2, Iborra Marisa3ORCID, Mesonero Francisco1, Vera Isabel1, Riestra Sabino4ORCID, García-Sánchez Valle5, Luisa De Castro M.6, Martin-Cardona Albert2ORCID, Aldeguer Xavier7, Mínguez Miguel3ORCID, de-Acosta Manuel Barreiro8, Rivero Montserrat9, Muñoz Fernando10, Andreu Montserrat2, Bargalló Ana2, González-Muñoza Carlos2, Pérez Calle Jose L.1, García-Sepulcre Mariana Fe11, Bermejo Fernando1, Huguet Jose Maria3ORCID, Cabriada José L.12ORCID, Gutiérrez Ana11, Mañosa Míriam2ORCID, Villoria Albert2, Carbajo Ana Y.13, Lorente Rufo14, García-López Santiago15, Piqueras Marta2ORCID, Hinojosa Esther3, Arajol Clàudia2ORCID, Sicilia Beatriz16, Conesa Ana Macho13, Sainz Empar17, Almela Pedro18, Llaó Jordina19, Roncero Oscar14, Camo Patricia20, Taxonera Carlos1, Domselaar Manuel Van1, Pajares Ramón1, Legido Jesús21, Madrigal Rosa22, Lucendo Alfredo J.14ORCID, Alcaín Guillermo23, Doménech Eugeni24ORCID, Gisbert Javier P.1ORCID,
Affiliation:
1. Madrid Spain 2. Barcelona Spain 3. Valencia Spain 4. Asturias Spain 5. Córdoba Spain 6. Vigo Spain 7. Gerona Spain 8. Santiago de Compostela Spain 9. Santander Spain 10. Salamanca Spain 11. Alicante Spain 12. Vizcaya Spain 13. Valladolid Spain 14. Ciudad Real Spain 15. Zaragoza Spain 16. Burgos Spain 17. Lleida Spain 18. Castellón Spain 19. Manresa Spain 20. Huesca Spain 21. Segovia Spain 22. Palencia Spain 23. Málaga Spain 24. Badalona Spain
Funder
Takeda Pharmaceutical Company Instituto de Salud Carlos III
Subject
Pharmacology (medical),Gastroenterology,Hepatology
Cited by
76 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|